November 20, 2020 Pharmaceutical Executive The Department of Justice is Watching: Building a Data-Driven Compliance Program
November 3, 2020 Device Company Settles Open Payment Program Reporting Violation, Agrees to Pay Over $9.2 Million
November 2, 2020 FDA Clarifies Types of Evidence Relevant to Determining the "Intended Use" of a Product
July 9, 2020 Massachusetts Department of Public Health Extends Pharmaceutical and Medical Device Manufacturer Registration Renewal Deadline in Response to COVID-19 Pandemic
May 29, 2020 John Patrick Oroho Interview with Global Business Reports US Biopharmaceuticals 2020 John Oroho
May 11, 2020 Utah Insurance Department Issues Bulletin Regarding Prescription Drug Price Transparency Act; Contact Information Due June 1, 2020